← IONQ overview

IONQ vs Rigetti Computing: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

IONQ Inc (IONQ)

Q3 2026
▲2▼2

IonQ expands via SkyWater, Superion, but Nvidia threat and losses weigh

  • SkyWater acquisition closes, Superion 256 launches IonQ closed its SkyWater acquisition, bringing a key hardware supplier in-house, and launched the Superion 256 platform with deployments at FIU and Nvidia. These moves expand its technology and customer base.

    These are major new operational milestones that drove positive sentiment.

  • Record Q2 revenue and raised guidance Q2 revenue hit a record $80.1 million, up 287%, and management raised full-year guidance to $450–460 million. New contracts and a Bank of America upgrade added credibility, supporting the bull case.

    Strong financial performance and analyst validation are key positive drivers.

  • Nvidia's growing supplier role threatens exclusivity Nvidia's expanding role as a supplier to IonQ's competitors threatens IonQ's technological exclusivity, contributing to a 37% share drop. This raises competition concerns and pressures the stock.

    This new competitive threat directly impacted investor confidence and the share price.

  • Severe cash burn and dilution risk IonQ burned $151 million last quarter, with a $272 million operating loss and a $1.87 billion net loss from earn-out accounting. Valuation near 97x sales, a Sell rating, and cut profit forecasts underscore lingering profitability concerns.

    These financial risks are critical negatives that weigh on the stock.

September 2026
▲3▼1

IonQ Surges on Superion Launch and Raised Guidance, But Profit Concerns Linger

  • Superion 256 Launch and Deployments IonQ launched its Superion 256 quantum platform, with the first on-premise deployment at Florida International University and a placement at NVIDIA's research center, signaling technical progress and commercial traction.

    This is a major new product launch and deployment that drove positive momentum.

  • Raised 2026 Revenue Guidance IonQ raised its 2026 revenue guidance to $450–460 million, implying over 100% organic growth, which boosted investor confidence in the company's commercial momentum.

    This is a significant new guidance increase that directly influenced the stock's rise.

  • New Contract and Analyst Upgrade IonQ secured an $8.18 million security contract and received a Buy rating from Bank of America with a $60 price target, adding to positive sentiment and credibility.

    These new developments provided additional validation and upward pressure on the stock.

  • Profitability Concerns Persist Despite revenue growth, IonQ's Q2 adjusted loss of 33 cents missed estimates, 2026 profit forecasts were cut by 41.76%, and analysts flagged a Sell rating amid heavy cash burn, keeping profitability distant.

    This counterweight highlights ongoing financial risks that capped upside.

Latest
▲4

IonQ's error-correction breakthrough and first on-premise Superion 256 deployment drive gains

  • Error-correction decoder milestone IonQ tested a real-time quantum error-correction decoder on a standard CPU, a key step toward practical quantum computers. The news sent shares up 12% and lifted the whole quantum sector, as it shows IonQ is solving a major technical hurdle that could speed up commercial adoption.

    This is the main new event that directly caused a double-digit stock jump and addresses a core technology risk.

  • First on-premise Superion 256 deployment at FIU IonQ will install its Superion 256 quantum computer at Florida International University, its first on-campus deployment. This puts real hardware in a research setting, proving the system works outside the lab and opening the door to more academic and commercial sales.

    It is a concrete new customer win that validates demand for IonQ's flagship product.

  • BofA initiates with Buy and $60 target Bank of America started covering IonQ with a Buy rating and a $60 price target, calling it the largest public pure-play quantum company by revenue. A major bank's endorsement can draw new investors and support the stock price.

    A new analyst rating from a top bank often influences investor sentiment and buying.

  • Superion 256 deployment at NVIDIA research center IonQ will place its Superion 256 quantum computer at NVIDIA's Accelerated Quantum Research Center, tying its hardware to NVIDIA's advanced computing infrastructure. This partnership with a tech leader adds credibility and a real-world testbed for scaling.

    It is a new high-profile collaboration that could accelerate commercial adoption and investor confidence.

August 2026
▲2▼1

IonQ's record revenue and deals offset by huge losses and dilution risk

  • Record Q2 revenue and raised guidance IonQ reported record Q2 revenue of $80.1 million, up 287%, and raised its 2026 revenue guidance to $280–290 million. A $485 million backlog and 60% commercial revenue show strong demand.

    This is the core positive fundamental news that drove investor optimism during the period.

  • Expansion via acquisitions and partnerships IonQ expanded through the SkyWater and Nexus Photonics acquisitions, plus new government, utility, and South Korea partnerships. These moves broaden its technology and customer base.

    These strategic actions are new developments that support future growth prospects.

  • Massive net loss and cash burn A $1.87 billion net loss from SkyWater earn-out accounting and a $272 million operating loss highlight heavy cash burn. This raises the risk of selling more shares, which would dilute existing investors.

    This is a major negative factor that weighs on the stock and investor confidence.

  • High valuation and analyst caution The stock trades near 97 times sales, which analysts call speculative and volatile. At least one Sell rating exists, and proposed 68% military quantum funding remains unapproved, adding uncertainty.

    This captures the valuation risk and policy uncertainty that balance the positive news.

▲3▼1

IonQ's record revenue and global expansion offset by heavy losses

  • Fifth straight record quarter and raised guidance IonQ reported its fifth consecutive record quarter and raised 2026 revenue guidance to $280–$290 million, with combined guidance of $450–$460 million after the SkyWater deal. This shows strong demand and execution, supporting a higher stock price over time.

    This is the core positive fundamental update that directly boosts investor confidence and valuation.

  • New partnerships and product deployments expand market reach IonQ signed a multi-year partnership with SDT to bring its Superion 256 quantum system to South Korea, and announced joint research with Synopsys showing quantum algorithms sped up industrial simulations by up to 14.6%. These moves open new markets and prove real-world usefulness, which can attract more customers and investors.

    These are new commercial and technological milestones that broaden IonQ's addressable market and credibility.

  • Massive operating losses and high valuation raise sustainability concerns IonQ reported a $272 million operating loss in the first quarter and continues to burn cash heavily. Its stock trades at about 97 times sales, far above the market average, and may need to issue more shares or debt if losses persist. This keeps a lid on the stock and adds risk for investors.

    This is the main counterweight that balances the positive news and explains why the stock hasn't risen more.

  • Technological progress in quantum optimization and chip integration IonQ developed a generative AI method for quantum optimization circuits with ~28-second generation time, and is moving to electronic qubit control using SkyWater-fabricated chips, with first integrated chips back for testing. These advances could lower costs and improve performance, supporting future growth.

    This shows tangible R&D progress that underpins IonQ's long-term competitive position.

▲3▼1

IonQ's new chip platform and raised outlook drive optimism

  • Superion 256 launch IonQ launched its sixth-generation Superion 256 quantum platform with 256-qubit chips, taking orders for 2027 delivery. This shows real technical progress and a path to far cheaper qubits, which supports the stock by making future growth look more achievable.

    This is a major new product launch that directly boosts IonQ's technology story and future revenue potential.

  • Raised 2026 revenue guidance IonQ raised its 2026 revenue outlook to $450–$460 million from $280–$290 million, implying over 100% organic growth. The stock jumped on the news, as higher guidance signals stronger demand and execution than previously expected.

    This is a direct, new financial update that changes the company's growth trajectory and investor expectations.

  • New $8.18M security contract IonQ won an $8.18 million commercial contract with Congruity360 for quantum security products. While small, it proves customers are buying beyond experimental systems, adding a revenue stream that doesn't depend on selling full quantum computers.

    This is a concrete new sale that validates commercial demand for IonQ's security offerings.

  • Widening losses and Sell rating IonQ's Q2 adjusted loss of 33 cents missed estimates, and analysts cut 2026 profit forecasts by 41.76%, tagging the stock a Sell. Cash burn is heavy, so even with strong revenue, profitability remains far off and keeps a lid on the stock.

    This is the main counterweight: it shows the financial risks that could hold the stock back despite positive news.

▲4

IonQ's demand story strengthens as it builds a supplier moat

  • Industry forecast backs IonQ's growth runway A new report projects the quantum computing market will grow from $1.93 billion in 2026 to $21.86 billion by 2035, about 31% a year. IonQ's record $80 million quarter is cited as proof demand is real, which supports a higher valuation over time.

    Shows the size and growth of the market IonQ sells into, the core reason its revenue can keep climbing.

  • IonQ named a leader on accuracy and commercial traction Coverage puts IonQ and Quantinuum ahead of rivals, crediting trapped-ion accuracy above 99.9% and IonQ's 287% revenue jump to $80.1 million, with 60% from commercial customers and a $485 million backlog. Leadership status draws investor money to the stock.

    Explains why IonQ is seen as the strongest pure-play name, which is what pulls buyers in.

  • Analysts still see big upside, but flag the risk Analysts see roughly 68% upside to IonQ from its $46.84 close, based on record Q2 revenue and raised $280–$290 million guidance. The same coverage calls the stock speculative and volatile, and one rating service tags it a Sell, so expectations are already high.

    Gives the fair counterweight: strong targets but a stretched, speculative setup that can cut both ways.

  • IonQ widens its supplier role beyond computers IonQ bought Nexus Photonics for chip-scale lasers and optics, and its Skyloom unit now has 84 laser terminals in orbit. Both push IonQ into supplying parts to the whole quantum and defense industry, adding revenue that does not depend on selling its own machines.

    New deals show a second growth engine and reduce reliance on one product line.

▲3▼1

IonQ's record Q2 and raised guidance overshadowed by huge loss

  • Record Q2 revenue and raised full-year guidance IonQ reported Q2 revenue of $80.1 million, up 287% from a year ago, and raised full-year guidance to $280–$290 million, above analyst expectations. This shows demand is strong and growing, which supports a higher stock price.

    This is the core new financial result that directly drives investor confidence and valuation.

  • Massive net loss from SkyWater acquisition accounting IonQ posted a $1.87 billion net loss, mostly a non-cash charge from revaluing SkyWater deal earn-outs. While not a cash drain, it highlights the cost and complexity of the acquisition and could worry investors about future dilution or integration risks.

    This is a major new negative that offsets the positive revenue news and explains why the stock may not rally as much.

  • New government and utility deals expand quantum networking IonQ announced partnerships with Sandia National Labs and EPB to advance quantum networking and security, including deploying quantum memory on a power grid. These deals open new markets and strengthen IonQ's position for federal contracts, though IonQ must fund $15 million over five years.

    These are new contracts that show commercial and government traction beyond computing, a key growth driver.

  • US lawmakers propose 68% boost in military quantum funding A bipartisan push seeks to raise annual military quantum spending to $567 million, part of broader federal support. This could mean more contracts for IonQ, boosting future revenue and investor optimism, though the funding is not yet approved.

    This is a new policy development that could significantly increase demand for quantum computing from the government.

July 2026
▼3▲1

IonQ expands via SkyWater, but Nvidia threat and cash burn weigh

  • SkyWater acquisition closes IonQ completed its $1.8 billion purchase of chipmaker SkyWater, giving it control over a key part of its hardware supply chain. This vertical integration could lower costs and speed up production.

    This is a major new strategic move that affects IonQ's supply and technology position.

  • Nvidia's growing supplier role Nvidia is becoming a bigger supplier to quantum computing firms, threatening IonQ's exclusivity. This contributed to a 37% drop in IonQ's share price as investors worried about competition.

    This is a new competitive threat that directly impacted the stock price this period.

  • Heavy cash burn and dilution risk IonQ burned $151 million last quarter and projects a $310–330 million EBITDA loss for the year. This raises the risk of selling more shares to raise cash, which would dilute existing investors.

    This is a key financial risk that weighs on the stock and is new information for this period.

  • Sector-wide AI sell-off A broad sell-off in AI-related stocks dragged down quantum computing shares, including IonQ. Even with strong company-specific news, the stock could not escape the negative sector sentiment.

    This external factor pressured IonQ's price during the period and is new.

▲2▼1

IonQ closes $1.8B SkyWater deal, gaining chip supply control

  • IonQ completes $1.8B SkyWater acquisition IonQ closed its $1.8 billion purchase of US chip foundry SkyWater, giving it full control of its chip supply chain and a trusted defense supplier. This vertical integration supports long-term growth and government contracts, and the stock jumped 9% on the news.

    This is the period's biggest new event and directly explains the stock's move.

  • IonQ's revenue growth far outpaces D-Wave IonQ's Q1 2026 revenue grew 755% to $64.7 million, while D-Wave's fell 81% to $2.9 million. This widening gap reinforces IonQ's commercial lead in quantum computing, attracting investors who want the strongest pure-play name.

    It shows the demand and competitive advantage behind IonQ's premium valuation.

  • Valuation looks stretched after the deal IonQ trades at about 50 times its own 2026 revenue forecast and 44 times earnings, far above tech peers. Analysts warn it may be fully priced, with bears seeing it overvalued by 620%, so any execution stumble could hit the stock hard.

    It is the main counterweight to the bullish news and a real risk for investors.

▲2▼2

IonQ's revenue surge and raised guidance offset by Nvidia competition and sector sell-off

  • IonQ raises full-year revenue guidance to $260–$270 million IonQ beat Q1 revenue estimates with $64.67 million, up 755% year over year, and raised full-year guidance to $260–$270 million. Backlog jumped over 550% to $470 million, with 60% from commercial customers. This signals strong demand and supports a higher valuation.

    This is the primary new positive catalyst that directly boosts investor confidence and the stock's fundamental outlook.

  • Nvidia's growing role in quantum sector pressures IonQ Nvidia is positioning itself as an essential supplier to all quantum computing firms, making IonQ's success less exclusive. IonQ shares fell 37% over the past month as investors worry that Nvidia could capture more value, reducing IonQ's potential upside.

    This new competitive threat explains a significant part of the recent stock decline and changes the investment narrative.

  • IonQ leads Rigetti commercially with 755% revenue growth IonQ's Q1 revenue of $64.7 million dwarfs Rigetti's $4.4 million, and its trapped-ion technology leads in gate fidelity. This commercial lead reinforces IonQ's position as the top pure-play quantum stock, attracting investor interest.

    This new comparison highlights IonQ's relative strength and supports its premium valuation versus peers.

  • Quantum stocks pull back amid AI infrastructure sell-off IonQ shares declined as part of a broader sell-off in AI infrastructure names, triggered by concerns over hyperscaler capital spending. No company-specific news drove the drop, but sector-wide risk aversion weighed on the stock.

    This new sector-wide pressure explains recent price weakness and highlights external risks to IonQ's stock.

▲3▼1

IonQ's tech lead and new markets offset by cash burn and sector risk

  • IonQ leads in 2-qubit gate fidelity IonQ achieved 99.99% two-qubit gate fidelity, the best among trapped-ion peers, thanks to its Oxford Ionics acquisition and chip-based controls. This strengthens its technology lead, supporting future demand and a premium valuation.

    A key technology milestone that reinforces IonQ's competitive edge and long-term pricing power.

  • Investors favor IonQ over pure-play peers Investors are rewarding commercial progress, and IonQ is gaining ground while D-Wave, Rigetti, and Quantum Computing Inc. decline. This shift supports IonQ's relative valuation and could attract more investment.

    Shows a market preference that directly benefits IonQ's stock versus competitors.

  • IonQ expands into cybersecurity and space IonQ launched Clavis XG Multiplex for quantum-safe security and commercial InSAR services for ground monitoring. These new markets broaden its addressable opportunity beyond computing, potentially driving future revenue.

    New business lines that could open additional revenue streams and support growth.

  • Cash burn and dilution risks persist IonQ guided to a $310–$330 million adjusted EBITDA loss and burned $151 million in operating cash last quarter. High R&D spending and potential shareholder dilution remain key risks, especially if sentiment cools.

    Highlights the main financial counterweight that could pressure the stock.

Q2 2026
▲2▼2

IonQ's strong sales offset by huge losses and new competition

  • Quantinuum IPO resets sector valuations Quantinuum's $15 billion Nasdaq debut creates a new, better-funded competitor and a fresh valuation yardstick. Investors rotated out of IonQ and peers, sending IonQ down 21% in a week even after record revenue. This pressures IonQ's premium price-to-sales multiple.

    Explains the main reason IonQ shares fell sharply this period.

  • Large losses and sky-high valuation IonQ posted a $96.8 million quarterly adjusted EBITDA loss and reaffirmed a full-year loss of $310–$330 million. Its forward price-to-sales ratio of 64 times dwarfs the industry median of 4.36, making the stock vulnerable when sentiment cools.

    Highlights the financial risk that weighs on the stock.

  • Record revenue growth and raised guidance IonQ's first-quarter revenue jumped 755% to $64.7 million, and management raised full-year guidance to $260–$270 million. The company holds $3.1 billion in cash. This strong demand and solid balance sheet support the long-term bull case.

    Shows the fundamental strength that underpins the stock despite recent selloff.

  • Technology lead and Q-Day demand IonQ's trapped-ion technology leads in accuracy with 99.99% two-qubit gate fidelity. Analysts highlight IonQ as a top pick to benefit from Q-Day, when quantum computers could break encryption, driving future demand for its systems.

    Points to IonQ's competitive edge and a major demand catalyst.

June 2026
▲2▼2

IonQ's strong sales offset by huge losses and new competition

  • Quantinuum IPO resets sector valuations Quantinuum's $15 billion Nasdaq debut creates a new, better-funded competitor and a fresh valuation yardstick. Investors rotated out of IonQ and peers, sending IonQ down 21% in a week even after record revenue. This pressures IonQ's premium price-to-sales multiple.

    Explains the main reason IonQ shares fell sharply this period.

  • Large losses and sky-high valuation IonQ posted a $96.8 million quarterly adjusted EBITDA loss and reaffirmed a full-year loss of $310–$330 million. Its forward price-to-sales ratio of 64 times dwarfs the industry median of 4.36, making the stock vulnerable when sentiment cools.

    Highlights the financial risk that weighs on the stock.

  • Record revenue growth and raised guidance IonQ's first-quarter revenue jumped 755% to $64.7 million, and management raised full-year guidance to $260–$270 million. The company holds $3.1 billion in cash. This strong demand and solid balance sheet support the long-term bull case.

    Shows the fundamental strength that underpins the stock despite recent selloff.

  • Technology lead and Q-Day demand IonQ's trapped-ion technology leads in accuracy with 99.99% two-qubit gate fidelity. Analysts highlight IonQ as a top pick to benefit from Q-Day, when quantum computers could break encryption, driving future demand for its systems.

    Points to IonQ's competitive edge and a major demand catalyst.

▲2▼2

IonQ's strong sales offset by huge losses and new competition

  • Quantinuum IPO resets sector valuations Quantinuum's $15 billion Nasdaq debut creates a new, better-funded competitor and a fresh valuation yardstick. Investors rotated out of IonQ and peers, sending IonQ down 21% in a week even after record revenue. This pressures IonQ's premium price-to-sales multiple.

    Explains the main reason IonQ shares fell sharply this period.

  • Large losses and sky-high valuation IonQ posted a $96.8 million quarterly adjusted EBITDA loss and reaffirmed a full-year loss of $310–$330 million. Its forward price-to-sales ratio of 64 times dwarfs the industry median of 4.36, making the stock vulnerable when sentiment cools.

    Highlights the financial risk that weighs on the stock.

  • Record revenue growth and raised guidance IonQ's first-quarter revenue jumped 755% to $64.7 million, and management raised full-year guidance to $260–$270 million. The company holds $3.1 billion in cash. This strong demand and solid balance sheet support the long-term bull case.

    Shows the fundamental strength that underpins the stock despite recent selloff.

  • Technology lead and Q-Day demand IonQ's trapped-ion technology leads in accuracy with 99.99% two-qubit gate fidelity. Analysts highlight IonQ as a top pick to benefit from Q-Day, when quantum computers could break encryption, driving future demand for its systems.

    Points to IonQ's competitive edge and a major demand catalyst.

Rigetti Computing Inc (RGTI)

Q3 2026
▲2▼2

Government grant finalized, revenue surges, but losses and valuation risks persist

  • CHIPS Act grant finalized with government stake The $100M CHIPS Act grant became final, with a small non-controlling U.S. government stake. This boosts Rigetti's cash and credibility, validating its technology and reducing financing risk.

    This is a new development that strengthens Rigetti's financial position and market perception.

  • Q2 revenue jumps 185% to $5.1M Q2 revenue jumped 185% to $5.1M, with cash reaching $393.7M and no debt. The first two 9-qubit systems were sold to commercial customers, and an $8.4M India order is on track.

    This shows accelerating commercial traction and a strong balance sheet, key drivers for investor optimism.

  • Operating losses widen to $28.1M, EPS miss Operating losses widened to $28.1M and EPS missed estimates, highlighting that profitability remains distant. This raises concerns about cash burn and future dilution.

    This is a new financial disclosure that underscores ongoing profitability challenges.

  • Extreme valuation and competitive pressure Valuation is extreme (price-to-sales above 490), and rivals IonQ and Quantinuum lead on two-qubit accuracy (over 99.9%) with far larger revenue and backlogs, threatening Rigetti's pricing power and deal flow.

    This highlights persistent competitive and valuation risks that could weigh on the stock.

August 2026
▲2▼1

Rigetti's CHIPS Grant Finalized as Commercial Sales Begin

  • CHIPS Act $100M Grant Becomes Final Rigetti signed a definitive agreement for $100 million in CHIPS Act R&D funding, with the U.S. government taking a small non-controlling stake. This turns a prior letter of intent into real cash for three research projects, strengthening the balance sheet and cutting funding risk.

    It is the period's biggest new event, converting earlier tentative government support into a binding award.

  • First Commercial System Sales Rigetti's first two 9-qubit systems delivered in 2026 went to commercial customers, not just governments or universities, and the $8.4 million India order stays on track for fourth-quarter revenue. This shows real paying demand beyond research budgets, supporting future revenue growth.

    It shows a new source of demand that could broaden Rigetti's customer base and revenue.

  • Rivals Pull Ahead on Accuracy IonQ and Quantinuum use trapped-ion technology with over 99.9% two-qubit accuracy, well ahead of Rigetti's, and both posted much larger revenue and backlogs. If customers pick the most accurate machines, Rigetti risks losing deals and pricing power to better-funded competitors.

    It is the main counterweight: Rigetti's technology lags rivals even as its funding and sales improve.

Latest
▲2▼1

Rigetti's CHIPS Grant Finalized as Commercial Sales Begin

  • CHIPS Act $100M Grant Becomes Final Rigetti signed a definitive agreement for $100 million in CHIPS Act R&D funding, with the U.S. government taking a small non-controlling stake. This turns a prior letter of intent into real cash for three research projects, strengthening the balance sheet and cutting funding risk.

    It is the period's biggest new event, converting earlier tentative government support into a binding award.

  • First Commercial System Sales Rigetti's first two 9-qubit systems delivered in 2026 went to commercial customers, not just governments or universities, and the $8.4 million India order stays on track for fourth-quarter revenue. This shows real paying demand beyond research budgets, supporting future revenue growth.

    It shows a new source of demand that could broaden Rigetti's customer base and revenue.

  • Rivals Pull Ahead on Accuracy IonQ and Quantinuum use trapped-ion technology with over 99.9% two-qubit accuracy, well ahead of Rigetti's, and both posted much larger revenue and backlogs. If customers pick the most accurate machines, Rigetti risks losing deals and pricing power to better-funded competitors.

    It is the main counterweight: Rigetti's technology lags rivals even as its funding and sales improve.

July 2026
▲2▼2

Government deals and revenue jump lift Rigetti, but losses and valuation risks persist

  • Government stake and CHIPS Act funding Over 60% odds of a U.S. government stake and a CHIPS Act letter of intent worth up to $100M (equity at a 15% discount) boost Rigetti's cash and credibility.

    This is a major new government backing that directly supports Rigetti's finances and validates its technology.

  • Q2 revenue jumps 185% to $5.1M Q2 revenue jumped 185% to $5.1M, showing strong growth, while cash stands at $393.7M with no debt, giving Rigetti a solid financial cushion.

    This is a key new financial update that demonstrates accelerating commercial traction and a healthy balance sheet.

  • Widening losses and EPS miss Operating losses widened to $28.1M and EPS missed estimates, highlighting that profitability remains distant despite revenue growth.

    This is a new negative financial detail that underscores ongoing challenges and could weigh on investor sentiment.

  • Extreme valuation and competition Valuation remains extreme (price-to-sales above 490) and IonQ dwarfs Rigetti commercially ($64.7M vs. $4.4M in Q1), with analysts warning of a potential plunge if results disappoint.

    This is a new warning about valuation and competitive pressure that poses a significant risk to the stock.

▲3

Rigetti's Government Backing and Quantum Roadmap Drive Gains

  • CHIPS Act Award and UK Investment Rigetti signed a letter of intent for up to $100 million from the U.S. CHIPS Act, with the government getting an equity stake at a 15% discount. It also plans to invest up to $100 million in the UK for a 1,000+ qubit quantum computer. This government backing boosts investor optimism and provides funding.

    This is a major new development that directly boosts Rigetti's capital and strategic position.

  • NSF-Funded TangleLab Deal Rigetti will partner with HPE and Pittsburgh Supercomputing Center to build TangleLab, a hybrid testbed funded by a $5 million NSF grant, using a 9-qubit Novera system. This gives Rigetti a practical foothold in government-backed research and validates its technology.

    This new deal expands Rigetti's government partnerships and demonstrates commercial progress.

  • Q2 Earnings: Revenue Beat, Loss Miss Rigetti's Q2 revenue surged 185% to $5.1 million, beating estimates, but adjusted loss per share was 5 cents, missing estimates, and operating loss widened to $28.1 million due to higher R&D and SG&A costs. Cash position remains strong at $393.7 million with no debt.

    This is the latest earnings report, showing both growth and ongoing losses, which affects investor sentiment.

  • Quantum Roadmap and Global Expansion Rigetti is advancing its quantum roadmap with new deployments, including a 9-qubit Novera system for TangleLab and a 108-qubit system for C-DAC in India. Its Cepheus system achieves high fidelity, and it targets 1,000 qubits in three years. This progress supports long-term growth prospects.

    This update highlights Rigetti's technological advancements and expanding commercial pipeline.

▲2▼1

Rigetti's Cash and Government Ties Shine, But Valuation and Weak Sales Weigh

  • Government stake odds high Prediction market traders see over 60% odds that the U.S. government takes a stake in Rigetti this year, which could bring fresh capital and strategic support. That potential backing makes the stock more attractive to investors betting on government help.

    This is a new catalyst that could directly boost Rigetti's capital and demand.

  • U.S.-based quantum hardware strategic Rigetti's U.S.-based Fab-1 facility and government-linked research could become vital if America treats domestic quantum capability as strategic infrastructure. That geopolitical angle may drive more government contracts and investor interest.

    It highlights a new geopolitical driver that could increase demand for Rigetti's technology.

  • Q1 revenue jump but profitability distant Rigetti's Q1 2026 revenue rose to $4.4 million from $1.5 million a year earlier, driven by Novera system deliveries and government contracts. However, with a $26 million quarterly operating loss and a price-to-sales ratio above 490, the stock remains highly risky and dependent on future catalysts.

    This new earnings report shows improving sales but also underscores the extreme valuation and lack of profits.

  • Competition and valuation concerns IonQ leads Rigetti in commercial quantum progress, with Q1 revenue of $64.7 million versus Rigetti's $4.4 million. Analysts also warn that Rigetti's sky-high valuation could trigger a plunge after its August 6 earnings report, especially if results don't justify the premium.

    This new analysis points to competitive weakness and overvaluation as key risks for the stock.

Q2 2026
▼2▲1

Government backing and Quantinuum IPO reshape Rigetti's outlook

  • Quantinuum IPO pulls capital and resets valuations Quantinuum's $1.68B IPO created a $15B pure-play quantum leader, pulling investor money out of Rigetti and forcing a sector-wide valuation reset. RGTI fell 9% on the news, as investors rotated toward the new, better-funded competitor.

    This event directly triggered a sharp selloff and changed how investors value Rigetti relative to peers.

  • U.S. government letter of intent for $100M The U.S. government signed a letter of intent to invest up to $100 million in Rigetti over three years. This non-dilutive funding validates the technology and extends Rigetti's cash runway, reducing near-term financing risk.

    Government backing is a major new positive catalyst that supports Rigetti's funding and credibility.

  • Analyst warns of 50% plunge on valuation and losses A report warns RGTI could drop 50% due to extreme valuation (price-to-sales of 663), inconsistent revenue, and steep losses. The Cepheus system still has too many errors for real-world use, and future capital raises could dilute shareholders.

    This highlights the key counterweight: despite government funding, fundamental risks remain severe.

  • Market separates quantum winners from losers Investors are now rewarding commercial traction over promises. IonQ is winning, while Rigetti and others decline. Rigetti's $4.4M quarterly revenue is tiny compared to IonQ's $64.7M, but its $569M cash and 108-qubit system keep it in the race.

    This shift in investor focus explains why Rigetti is under pressure despite technological progress.

June 2026
▼2▲1

Government backing and Quantinuum IPO reshape Rigetti's outlook

  • Quantinuum IPO pulls capital and resets valuations Quantinuum's $1.68B IPO created a $15B pure-play quantum leader, pulling investor money out of Rigetti and forcing a sector-wide valuation reset. RGTI fell 9% on the news, as investors rotated toward the new, better-funded competitor.

    This event directly triggered a sharp selloff and changed how investors value Rigetti relative to peers.

  • U.S. government letter of intent for $100M The U.S. government signed a letter of intent to invest up to $100 million in Rigetti over three years. This non-dilutive funding validates the technology and extends Rigetti's cash runway, reducing near-term financing risk.

    Government backing is a major new positive catalyst that supports Rigetti's funding and credibility.

  • Analyst warns of 50% plunge on valuation and losses A report warns RGTI could drop 50% due to extreme valuation (price-to-sales of 663), inconsistent revenue, and steep losses. The Cepheus system still has too many errors for real-world use, and future capital raises could dilute shareholders.

    This highlights the key counterweight: despite government funding, fundamental risks remain severe.

  • Market separates quantum winners from losers Investors are now rewarding commercial traction over promises. IonQ is winning, while Rigetti and others decline. Rigetti's $4.4M quarterly revenue is tiny compared to IonQ's $64.7M, but its $569M cash and 108-qubit system keep it in the race.

    This shift in investor focus explains why Rigetti is under pressure despite technological progress.

▼2▲1

Government backing and Quantinuum IPO reshape Rigetti's outlook

  • Quantinuum IPO pulls capital and resets valuations Quantinuum's $1.68B IPO created a $15B pure-play quantum leader, pulling investor money out of Rigetti and forcing a sector-wide valuation reset. RGTI fell 9% on the news, as investors rotated toward the new, better-funded competitor.

    This event directly triggered a sharp selloff and changed how investors value Rigetti relative to peers.

  • U.S. government letter of intent for $100M The U.S. government signed a letter of intent to invest up to $100 million in Rigetti over three years. This non-dilutive funding validates the technology and extends Rigetti's cash runway, reducing near-term financing risk.

    Government backing is a major new positive catalyst that supports Rigetti's funding and credibility.

  • Analyst warns of 50% plunge on valuation and losses A report warns RGTI could drop 50% due to extreme valuation (price-to-sales of 663), inconsistent revenue, and steep losses. The Cepheus system still has too many errors for real-world use, and future capital raises could dilute shareholders.

    This highlights the key counterweight: despite government funding, fundamental risks remain severe.

  • Market separates quantum winners from losers Investors are now rewarding commercial traction over promises. IonQ is winning, while Rigetti and others decline. Rigetti's $4.4M quarterly revenue is tiny compared to IonQ's $64.7M, but its $569M cash and 108-qubit system keep it in the race.

    This shift in investor focus explains why Rigetti is under pressure despite technological progress.

© 2026 MarketDXWhy